Protein Degradation and Inhibitors

Работ: 9

1. Targeted Protein Degradation in Cancer: PROTACs, New Targets, and Clinical Mechanisms

   Bushra Faryal, Zain Ul Abideen, Muhammad Irfan +4

   СтатьяProtein Degradation and InhibitorsBiomolecules2026Цитирований: 2

   ABIABI:AkademIndex/openalex/2026.article.000038

2. Mutational Profiling of Pediatric Myeloid Leukemia Subtypes without Clinically Significant Chromosomal Aberrations

   Lilit Ghukasyan, George S. Krasnov, О. В. Муравенко +3

   СтатьяAcute Myeloid Leukemia ResearchMolecular Biology2019Цитирований: 1

   ABIABI:AkademIndex/openalex/2026.other.574579

3. createtls215citncateg.sql

   European Patent Office

   ДругоеProtein Degradation and InhibitorsHarvard Dataverse2020Цитирований: 0

   ABIABI:AkademIndex/openalex/2020.other.000139

4. MAQOLA YOZAMAN SHE'RNI TO'XTATIB

   Mulikboyev O'tkir Qo'chqor o'g'li, Soliyeva Dildora

   СтатьяSynthesis of β-Lactam CompoundsZenodo (CERN European Organization for Nuclear Research)2022Цитирований: 0

   ABIABI:AkademIndex/openalex/2022.article.016531

5. Flag-TBK1 N455S and Flag-TBK1 M559R cloning (NEB Site directed mutagenesis kit, #E0554S) v1

   Jailyn Izu

   ПрепринтUbiquitin and proteasome pathways2024Цитирований: 0

   ABIABI:AkademIndex/openalex/2024.preprint.000253

6. Alterations in 3D Chromatin Spatial Organisation in Tumourigenesis and Therapy Resistance of Glioblastoma: The Recent Advances in Understanding Molecular Mechanisms, Clinical Implications, and Therapeutic Perspectives

   ‎Anmar Ghanim Taki, Abdulkareem Shareef, Lalji Baldaniya +10

   СтатьяGenomics and Chromatin DynamicsClinical Oncology2025Цитирований: 0

   ABIABI:AkademIndex/openalex/2025.article.002218

7. AML-095: Loss of Sex Chromosome in Acute Myeloid Leukemia

   Doskhan Orazkhanov, M Islamov, Zulkhumor Yunusova +1

   СтатьяAcute Myeloid Leukemia ResearchClinical Lymphoma Myeloma & Leukemia2025Цитирований: 0

   ABIABI:AkademIndex/openalex/2025.article.003181

8. Structure-driven design and precision translation of functionally diverse isatin-based CDK2 inhibitors: Advances in SAR, polypharmacology, and biomarker-guided cancer therapy

   Safia Obaidur Rab, A. Al-Shahrani, Lalji Baldaniya +9

   СтатьяCancer-related Molecular PathwaysJournal of Molecular Structure2025Цитирований: 0

   ABIABI:AkademIndex/openalex/2025.article.010865

9. Targeted Protein Degradation and Delivery Strategies in the Context of Neurological Disorders

   Haoran Lu, Zixiao Yang, Muzaffar Kayumov +7

   СтатьяProtein Degradation and InhibitorsACS Nano2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.014466